Activated protein C resistance in pediatric inflammatory bowel disease

Arie Levine, Judith Lahav, Ilan Zahavi, Arie Raz, Gabriel Dinari*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Background: There is evidence for a hypercoagulable state in inflammatory bowel disease (IBD), and small vessel thrombosis has been identified in the bowel of patients with Crohn's disease, suggesting thrombosis as a possible etiologic factor. Activated protein C (APC) resistance is the most common inherited disorder leading to thrombosis and accounts for 30% to 40% of episodes of idiopathic venous thrombosis. Methods: The prevalence of APC resistance was studied in 23 patients with IBD (17 with Crohn's disease, 6 with ulcerative colitis) and in 11 control subjects with recurrent abdominal pain or celiac disease, using an APC resistance screening method. Results: One patient with Crohn's disease had a positive screen result, two patients (one with Crohn's, one with ulcerative colitis) had borderline results, and results in all of the control subjects were normal. One patient with Crohn's disease had a history of a thromboembolic event but had a normal screen result. Conclusions: Activated protein C resistance does not seem to play a major role in the etiology of the hypercoagulable state in inflammatory bowel disease.

Original languageEnglish
Pages (from-to)172-174
Number of pages3
JournalJournal of Pediatric Gastroenterology and Nutrition
Issue number2
StatePublished - Feb 1998
Externally publishedYes


  • Children
  • Crohn's disease
  • Hypercoagulability
  • Inflammatory bowel disease
  • Protein C resistance
  • Ulcerative colitis


Dive into the research topics of 'Activated protein C resistance in pediatric inflammatory bowel disease'. Together they form a unique fingerprint.

Cite this